BI Asset Management Fondsmaeglerselskab A S Has $25.41 Million Stock Holdings in Cardinal Health, Inc. $CAH

BI Asset Management Fondsmaeglerselskab A S trimmed its holdings in Cardinal Health, Inc. (NYSE:CAH) by 19.2% in the 1st quarter, HoldingsChannel.com reports. The fund owned 120,252 shares of the company’s stock after selling 28,541 shares during the quarter. BI Asset Management Fondsmaeglerselskab A S’s holdings in Cardinal Health were worth $25,410,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of the business. Aventura Private Wealth LLC bought a new position in shares of Cardinal Health during the 4th quarter valued at $25,000. University of Texas Texas AM Investment Management Co. bought a new stake in Cardinal Health in the fourth quarter worth $26,000. Bank of Jackson Hole Trust acquired a new position in Cardinal Health during the fourth quarter worth $27,000. Jones Financial Companies Lllp increased its position in Cardinal Health by 198.3% during the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after buying an additional 14,034 shares during the last quarter. Finally, Palladiem LLC bought a new position in Cardinal Health during the fourth quarter valued at about $28,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on CAH shares. JPMorgan Chase & Co. reduced their price target on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating for the company in a research report on Monday, May 4th. William Blair started coverage on Cardinal Health in a report on Tuesday, April 28th. They set an “outperform” rating on the stock. Wall Street Zen downgraded Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Monday, June 15th. Morgan Stanley boosted their target price on Cardinal Health from $245.00 to $255.00 and gave the stock an “overweight” rating in a report on Tuesday, April 28th. Finally, Barclays upped their target price on Cardinal Health from $243.00 to $258.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 24th. Fourteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $246.93.

Cardinal Health Price Performance

CAH stock opened at $222.08 on Friday. Cardinal Health, Inc. has a 52-week low of $137.75 and a 52-week high of $233.60. The company has a 50-day moving average of $204.34 and a two-hundred day moving average of $209.27. The stock has a market capitalization of $52.01 billion, a price-to-earnings ratio of 33.96, a price-to-earnings-growth ratio of 1.21 and a beta of 0.52.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.79 by $0.38. The company had revenue of $60.94 billion for the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The firm’s revenue was up 11.0% compared to the same quarter last year. During the same period last year, the business posted $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Equities analysts expect that Cardinal Health, Inc. will post 10.76 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be issued a $0.5158 dividend. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $2.06 dividend on an annualized basis and a yield of 0.9%. Cardinal Health’s payout ratio is 31.19%.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.